Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: BRS007
MIFTS: 45

Breast Malignant Phyllodes Tumor

Categories: Cancer diseases, Rare diseases, Reproductive diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Breast Malignant Phyllodes Tumor

About this section

MalaCards integrated aliases for Breast Malignant Phyllodes Tumor:

Name: Breast Malignant Phyllodes Tumor 12 15
Cystosarcoma Phyllodes of the Breast 52 58
Malignant Phyllodes Tumor of Breast 12 71
Malignant Cystosarcoma Phyllodes 12 71
Phyllodes Tumor of the Breast 52 58
Phyllodes Breast Tumor 12 52
Malignant Mammary Phyllodes Tumor 12
Malignant Breast Phyllodes Tumor 17
Malignant Phyllodes Neoplasm 12
Phyllodes Tumor, Malignant 12
Malignant Phyllodes Tumor 12
Phyllodes Breast Neoplasm 12
Cystosarcoma Phyllodes 52
Breast Phyllodes Tumor 71
Phylloides Tumor 52
Phyllodes Tumor 71

Characteristics:

Orphanet epidemiological data:

58
phyllodes tumor of the breast
Age of onset: Adult;

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Reproductive diseases
See all MalaCards categories (disease lists)
ICD10: 33
Orphanet: 58  
Rare gynaecological and obstetric diseases


External Ids:

Disease Ontology 12 DOID:3016
MeSH 43 D003557
SNOMED-CT 67 87913009
MESH via Orphanet 44 D003557
ICD10 via Orphanet 33 D48.6
UMLS via Orphanet 72 C0010701
Orphanet 58 ORPHA180261
UMLS 71 C0010701 C0238031 C0346154 more
Sources

Summaries for Breast Malignant Phyllodes Tumor

About this section
NIH Rare Diseases : 52 Phyllodes tumors of the breast are rare tumors that start in the connective (stromal) tissue of the breast. They get their name from the leaf-like pattern in which they grow (phyllodes means leaf-like in Greek). They are most common in women in their 30s and 40s, although women of any age can be affected. These tumors, which are usually painless, tend to grow quickly, but rarely spread outside of the breast. Most phyllodes tumors are benign. About 1 in 10 are cancerous. The underlying cause of these tumors in unknown. Surgery is the main treatment. Because the tumors can reoccur if they are not removed with enough surrounding tissue, the tumor and at least 1 cm of tissue should be removed. Cancerous phyllodes tumors are often treated with mastectomy. Close follow-up with frequent breast examinations are recommended after surgery.

MalaCards based summary : Breast Malignant Phyllodes Tumor, also known as cystosarcoma phyllodes of the breast, is related to li-fraumeni syndrome and scirrhous adenocarcinoma. An important gene associated with Breast Malignant Phyllodes Tumor is SERPINA3 (Serpin Family A Member 3), and among its related pathways/superpathways are MAPK signaling pathway and Pathways in cancer. The drugs Fluorouracil and Belinostat have been mentioned in the context of this disorder. Affiliated tissues include breast, prostate and lung, and related phenotypes are cellular and integument

Disease Ontology : 12 A breast cancer that is characterized by a prominent infiltrative border, unequivocal sarcomatous areas, and stromal overgrowth and arises from the stroma, lined by an epithelial and myoepithelial bilayer, forming a leaflike structure. They tend to grow rapidly and present in middle-aged women (40s-50s).

Sources

Related Diseases for Breast Malignant Phyllodes Tumor

About this section

Diseases in the Benign Breast Phyllodes Tumor family:

Breast Malignant Phyllodes Tumor

Diseases related to Breast Malignant Phyllodes Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 507)
# Related Disease Score Top Affiliating Genes
1 li-fraumeni syndrome 31.8 TP53 ESR1 ERBB2 EGFR
2 scirrhous adenocarcinoma 30.9 PGR ERBB2
3 gynecomastia 30.9 PGR ESR1 ERBB2
4 soft tissue sarcoma 30.8 TP53 EGFR
5 benign mesothelioma 30.6 KRT5 CD34
6 leiomyoma, uterine 30.5 PGR MED12 ESR1
7 malignant mesenchymoma 30.5 SERPINA3 CD34
8 benign breast phyllodes tumor 30.4 PGR MME MED12 KIT
9 bilateral breast cancer 30.3 PGR ESR1 ERBB2
10 mesenchymoma 30.2 SERPINA3 KIT CD34
11 spindle cell carcinoma 30.2 PGR KRT5 ESR1 CD34
12 hypertrophy of breast 30.2 TP53 PGR ESR1 ERBB2
13 female breast cancer 30.2 TP53 PGR ESR1 ERBB2
14 angiosarcoma 30.0 TP53 KIT CD34
15 histiocytoma 30.0 TP53 SERPINA3 KIT CD34
16 adenocarcinoma 30.0 TP53 KIT ERBB2 EGFR
17 embryonal sarcoma 30.0 TP53 SERPINA3 KIT
18 neurilemmoma 29.9 SERPINA3 KIT CD34
19 mammary paget's disease 29.9 PGR ESR1 ERBB2 EGFR
20 intraductal papilloma 29.8 PGR KRT5 ESR1 ERBB2
21 prostatic hypertrophy 29.8 SERPINA3 PGR ESR1 EGFR
22 inflammatory breast carcinoma 29.7 PGR ESR1 ERBB2 EGFR
23 breast fibroadenoma 29.7 TP53 SERPINA3 PGR MME MED12 ESR1
24 lobular neoplasia 29.7 TP53 PGR KRT5 ESR1 ERBB2
25 tubular adenocarcinoma 29.7 PGR MME ESR1 ERBB2 EGFR
26 papilloma 29.5 TP53 KRT5 ESR1 EGFR
27 leiomyosarcoma 29.5 TP53 SERPINA3 PGR MED12 KIT ESR1
28 breast disease 29.4 TP53 SERPINA3 PGR KRT5 ESR1 ERBB2
29 microglandular adenosis 29.3 TP53 PGR ESR1 ERBB2 EGFR
30 in situ carcinoma 29.3 TP53 PGR KRT5 ESR1 ERBB2 EGFR
31 mesenchymal cell neoplasm 29.2 TP53 SERPINA3 MME KIT CD34
32 leiomyoma 29.1 PGR MME MED12 KIT ESR1 CD34
33 cribriform carcinoma 29.1 PGR KRT5 KIT ESR1 ERBB2
34 gastrointestinal stromal tumor 29.0 TP53 KIT ERBB2 EGFR CD34
35 breast adenocarcinoma 29.0 TP53 SERPINA3 PGR MED12 ESR1 ERBB2
36 breast sarcoma 28.8 TP53 PGR MME ESR1 ERBB2 CD34
37 carcinosarcoma 28.7 TP53 PGR MME KIT ERBB2 EGFR
38 adenosarcoma 28.6 TP53 SERPINA3 PGR MME KIT ESR1
39 ductal carcinoma in situ 28.5 TP53 PGR MME KRT5 ESR1 ERBB2
40 benign prostate phyllodes tumor 11.5
41 li-fraumeni syndrome 2 11.4
42 rare tumor 10.7
43 sarcoma 10.6
44 spindle cell sarcoma 10.6
45 liposarcoma 10.5
46 rare breast tumor 10.5
47 fibrosarcoma 10.5
48 adenoma 10.5
49 congenital epulis 10.5 SERPINA3 PGR
50 epulis 10.5 SERPINA3 PGR

Graphical network of the top 20 diseases related to Breast Malignant Phyllodes Tumor:



Diseases related to Breast Malignant Phyllodes Tumor
Sources

Symptoms & Phenotypes for Breast Malignant Phyllodes Tumor

About this section

MGI Mouse Phenotypes related to Breast Malignant Phyllodes Tumor:

45 (show all 11)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.19 CD34 EGFR ERBB2 ESR1 KIT MED12
2 integument MP:0010771 10.1 CD34 EGFR ERBB2 ESR1 KIT KRT5
3 embryo MP:0005380 9.98 EGFR ERBB2 ESR1 KIT MED12 PGR
4 limbs/digits/tail MP:0005371 9.97 EGFR ERBB2 ESR1 KIT KRT5 MED12
5 craniofacial MP:0005382 9.95 EGFR ERBB2 KIT KRT5 MED12 TP53
6 digestive/alimentary MP:0005381 9.93 EGFR ERBB2 ESR1 KIT KRT5 TP53
7 muscle MP:0005369 9.87 EGFR ERBB2 ESR1 KIT MOCS2 PGR
8 neoplasm MP:0002006 9.8 CD34 EGFR ERBB2 ESR1 KIT PGR
9 no phenotypic analysis MP:0003012 9.63 EGFR ESR1 KIT KRT5 PGR TP53
10 normal MP:0002873 9.5 EGFR ERBB2 ESR1 KIT MED12 PGR
11 skeleton MP:0005390 9.17 EGFR ERBB2 ESR1 KIT MED12 PGR
Sources

Drugs & Therapeutics for Breast Malignant Phyllodes Tumor

About this section

Drugs for Breast Malignant Phyllodes Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fluorouracil Approved Phase 1 51-21-8 3385
2
Belinostat Approved, Investigational Phase 1 866323-14-0
3
Parathyroid hormone Approved, Investigational Phase 1 9002-64-6
4 Immunologic Factors Phase 1
5 Histone Deacetylase Inhibitors Phase 1
6 Antimetabolites Phase 1
7 Androgens Phase 1
8 Immunosuppressive Agents Phase 1

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Phase I Safety, Pharmacodynamic, Anti-Tumor Activity, and Pharmacokinetic Study of PXD101 Alone and in Combination With 5-Fluorouracil in Patients With Advanced Solid Tumors Completed NCT00413322 Phase 1 belinostat;5-Fluorouracil (5-FU)
2 A Prospective Study of Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors Completed NCT00003404
3 A Prospective Study of Partial Breast Adjuvant Radiation Therapy After Resection of Borderline and Malignant Phyllodes Tumors Recruiting NCT01089374

Search NIH Clinical Center for Breast Malignant Phyllodes Tumor

Sources

Genetic Tests for Breast Malignant Phyllodes Tumor

About this section
Sources

Anatomical Context for Breast Malignant Phyllodes Tumor

About this section

MalaCards organs/tissues related to Breast Malignant Phyllodes Tumor:

40
Breast, Prostate, Lung, Bone, Liver, Skin, Thymus
Sources

Publications for Breast Malignant Phyllodes Tumor

About this section

Articles related to Breast Malignant Phyllodes Tumor:

(show top 50) (show all 218)
# Title Authors PMID Year
1
Lacrimal Sac Metastasis from Phyllodes Tumor of the Breast. 61
32037753 2020
2
Phyllodes Tumor of the Breast: A Clinicopathological Evaluation of 55 Cases. 61
31912011 2020
3
Radiotherapy with apatinib for recurrence of malignant phyllodes tumor of the breast: A case report. 61
32011486 2020
4
The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study. 61
31612021 2019
5
A rare case of a malignant phyllodes tumor of the breast associated with secretion of beta-human chorionic gonadotropin. 61
31192485 2019
6
Giant phyllodes tumor of the breast. 61
31486153 2019
7
Transcatheter arterial chemoembolization improves the resectability of malignant breast phyllodes tumor with angiosarcoma component: a case report. 61
31351458 2019
8
Cytologic diagnosis of metastatic malignant phyllodes tumor of the breast in pleural effusion. 61
30829462 2019
9
Malignant phyllodes tumor of the breast with liposarcomatous differentiation: A case report with imaging findings. 61
30834064 2019
10
Phyllodes tumors of the breast. The treatment results for 340 patients from a single cancer centre. 61
30521986 2019
11
Not Every Fat-Containing Lesion on Mammogram is a Benign Finding: Case Report and Review of Breast Malignant Phyllodes Tumor with Heterologous Liposarcomatous Differentiation. 61
31448161 2019
12
Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience. 61
31695485 2019
13
Recurrent borderline phyllodes tumor of the breast submitted to mastectomy and immediate reconstruction: Case report. 61
31195364 2019
14
Phyllodes tumor of the breast with nipple discharge: A case report. 61
30593154 2018
15
Percutaneous removal of benign phyllodes tumor of the breast: An alternative to surgery. 61
30251456 2018
16
Radiopathological characteristics and outcomes of phyllodes tumor of the breast in Malaysian women. 61
30075507 2018
17
Metastatic giant malignant phyllodes tumor of the breast. 61
29139587 2018
18
Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. 61
29412020 2018
19
Early stage malignant phyllodes tumor case report. 61
29247967 2018
20
Malignant Phyllodes Tumor of the Breast with Metastasis to the Pancreas: A Case Report and Review of Literature. 61
30050709 2018
21
Phyllodes tumor masquerading as a fungating breast mass. 61
29250309 2017
22
Recurrent malignant phyllodes tumor of the breast: A case report. 61
29245318 2017
23
A rare presentation of malignant phyllodes tumor with bloody nipple discharge-report of a case. 61
28861384 2017
24
Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data. 61
28013032 2017
25
Giant phyllodes tumor of the breast with diffuse myxoid changes in an adolescent girl: a case report. 61
28458828 2017
26
Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report. 61
28103951 2017
27
A giant phyllodes tumor of the breast causing severe disfigurement. A case report. 61
28406095 2017
28
Clinicopathology and treatment of a giant malignant phyllodes tumor of the breast: A case report and literature review. 61
29121581 2017
29
Phyllodes Tumor of the Breast: Analysis of 48 Patients. 61
28331755 2016
30
A Giant Phyllodes Tumor of the Breast. 61
27746880 2016
31
A Case of Giant Borderline Phyllodes Tumor of the Breast Associated with Hypoglycemia. 61
27628602 2016
32
Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast. 61
27137988 2016
33
Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival: A case report and literature review. 61
27661051 2016
34
Giant malignant phyllodes tumor of the breast: A rare case report and literature review. 61
27347111 2016
35
Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. 61
27362571 2016
36
Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch? 61
26577125 2016
37
Treatment of Patients with Distant Metastases from Phyllodes Tumor of the Breast. 61
26464157 2016
38
The largest and neglected giant phyllodes tumor of the breast-A case report and literature review. 61
27475116 2016
39
Coexistence of malignant phyllodes tumor and her2-positive locally advanced breast cancer in distinct breasts: A case report. 61
26773878 2016
40
"Ruptured" malignant phyllodes tumor of the breast: a case report. 61
26952179 2016
41
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast. 61
26625196 2016
42
Phyllodes Tumor of the Breast: 307 Treated Cases, the Largest Mexican Experience at a Single Breast Disease Institution. 61
28855932 2016
43
Metastatic Malignant Phyllodes Tumor of the Breast: An Aggressive Disease-Analysis of 7 Cases. 61
27065662 2015
44
Malignant phyllodes tumor of the breast with isolated intracranial metastases: A report. 61
26588634 2015
45
[Pulmonary Metastasis from a Phyllodes Tumor of the Breast Developing Sixteen Years after Initial Surgery]. 61
26555915 2015
46
Pleomorphic liposarcoma arising in a malignant phyllodes tumor of breast: A rare occurrence. 61
26881623 2015
47
Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort. 61
26600624 2015
48
Phyllodes Tumor of the Breast With Malignant Melanoma Component: A Case Report. 61
26113664 2015
49
A Rare Case of Breast Malignant Phyllodes Tumor With Metastases to the Kidney: Case Report. 61
26287414 2015
50
Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing. 61
25900796 2015
Sources

Variations for Breast Malignant Phyllodes Tumor

About this section
Sources

Expression for Breast Malignant Phyllodes Tumor

About this section
Search GEO for disease gene expression data for Breast Malignant Phyllodes Tumor.
Sources

Pathways for Breast Malignant Phyllodes Tumor

About this section

Pathways related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(show all 18)
# Super pathways Score Top Affiliating Genes
1
MAPK signaling pathway 36 1
12.54 TP53 KIT ERBB2 EGFR
2
Pathways in cancer 36
12.53 TP53 KIT ESR1 ERBB2 EGFR
3
Downstream signaling events of B Cell Receptor (BCR) 65
Show member pathways
 12.49 TP53 KIT ERBB2 EGFR
4
Glioma 36
Show member pathways
 12.43 TP53 ESR1 ERBB2 EGFR
5
Gastric cancer 36
Show member pathways
 12.1 TP53 PGR KIT ESR1 ERBB2 EGFR
6
Integrated Breast Cancer Pathway 1
11.93 TP53 ESR1 EGFR
7
Proteoglycans in cancer 36
11.93 TP53 ESR1 ERBB2 EGFR
8
Tyrosine Kinases / Adaptors 4
11.9 KIT ERBB2 EGFR
9
MAPK Pathway 70
Show member pathways
 11.79 TP53 ERBB2 EGFR
10
Thyroid hormone signaling pathway 36
11.76 TP53 MED12 ESR1
11
Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers 64
11.74 MME KIT CD34
12
Hematopoietic cell lineage 36
11.65 MME KIT CD34
13
Signaling by ERBB4 65
Show member pathways
 11.59 PGR ESR1 ERBB2 EGFR
14
Dendritic Cells Developmental Lineage Pathway 64
11.5 MME KIT CD34
15
Bladder cancer 36 1
11.47 TP53 ERBB2 EGFR
16
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors 65
Show member pathways
 11.43 KIT ESR1 ERBB2 EGFR
17
B Cell Development Pathways 64
11.27 MME KIT CD34
18
Central carbon metabolism in cancer 36
10.76 TP53 KIT ERBB2 EGFR
Sources

GO Terms for Breast Malignant Phyllodes Tumor

About this section

Cellular components related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 basal plasma membrane GO:0009925 8.8 ERBB2 EGFR CD34

Biological processes related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.86 TP53 KIT ERBB2 CD34
2 peptidyl-tyrosine phosphorylation GO:0018108 9.72 KIT ERBB2 EGFR
3 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.71 KIT ERBB2 EGFR
4 negative regulation of gene expression GO:0010629 9.67 TP53 PGR ESR1 CD34
5 wound healing GO:0042060 9.63 TP53 ERBB2 EGFR
6 replicative senescence GO:0090399 9.52 TP53 MME
7 positive regulation of phospholipase C activity GO:0010863 9.51 KIT ESR1
8 tongue development GO:0043586 9.49 KIT EGFR
9 positive regulation of RNA polymerase II transcriptional preinitiation complex assembly GO:0045899 9.48 TP53 ESR1
10 positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800 9.43 TP53 EGFR
11 negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799 9.4 TP53 ESR1
12 positive regulation of MAP kinase activity GO:0043406 9.33 KIT ERBB2 EGFR
13 paracrine signaling GO:0038001 9.32 PGR CD34
14 negative regulation of ERBB signaling pathway GO:1901185 9.26 ERBB2 EGFR
15 positive regulation of protein kinase B signaling GO:0051897 9.26 KIT ESR1 ERBB2 EGFR
16 regulation of transcription by RNA polymerase II GO:0006357 9.1 TP53 MED12 KIT ESR1 ERBB2 EGFR

Molecular functions related to Breast Malignant Phyllodes Tumor according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chromatin binding GO:0003682 9.71 TP53 MED12 ESR1 EGFR
2 enzyme binding GO:0019899 9.62 TP53 PGR ESR1 EGFR
3 transcription factor binding GO:0008134 9.56 TP53 MED12 ESR1 CD34
4 protein tyrosine kinase activity GO:0004713 9.54 KIT ERBB2 EGFR
5 protein phosphatase binding GO:0019903 9.33 TP53 ERBB2 EGFR
6 nitric-oxide synthase regulator activity GO:0030235 8.96 ESR1 EGFR
7 transmembrane receptor protein tyrosine kinase activity GO:0004714 8.8 KIT ERBB2 EGFR
Sources

Sources for Breast Malignant Phyllodes Tumor

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....